You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明生物(02269.HK)旗下藥明合聯無錫基地新廠房投產
藥明生物(02269.HK)與藥明康德(02359.HK)(603259.SH)子公司合全藥業共同成立的合資公司藥明合聯宣布,旗下位於江蘇無錫的新商業化廠房(XBCM2和XDP2)已於近日成功啟動GMP生產,將實現產能翻倍,預料可協助客戶快速推動商業化生產,賦能需求激增的全球生物偶聯藥產業。 此次投產的無錫基地新GMP生產設施佔地近7,000平方米,包括生物偶聯藥物抗體中間體和原液雙功能生產線XBCM2和生物偶聯製劑生產線XDP2,以及產品檢測和商業包裝線。廠房採用先進的自動化系統和生產設備,為ADC及更廣泛的生物偶聯藥提供在臨床和商業化階段的全方位一站式GMP生產,從而滿足生物偶聯藥開發和生產的需求。(gc/w) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account